Top Companies in Mass Spectrometry Market

The global mass spectrometry market is estimated to reach USD 9.62 billion by 2030 from USD 6.33 billion in 2024, at a CAGR of 7.2% during the forecast period.

The pharmaceutical industry's allocation of larger budgets for research and development and government regulation on drug safety will increase demand for mass spectrometers. Increasing investments in energy exploration and climate studies will stimulate demand for mass spectrometers. Also, the sensitive qualitative and quantitative mandates for food and beverage testing are expected to increase the demand in the mass spectrometry market.

To know about the assumptions considered for the study download the pdf brochure

Increasing capital expenditure on pharmaceutical R&D primarily drives the growth of this market in mass spectrometry, government regulations on drug safety, and growing focus on the quality of food products further support the market growth. However, the shortage of skilled technicians and the high cost of equipment are expected to shrink the market for mass spectrometry.

The competitive landscape for the mass spectrometry market is composed of some strong multinational players that acquire a major share of the market, while at the same time, some of the SME's and regional players hold a measurable position in the market. Major players that operate in the mass spectrometry market are Agilent Technologies, Inc. (US), Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US) Waters Corporation (US), Bruker Corporation (US), Shimadzu Corporation (Japan), PerkinElmer, Inc (US) Jeol, Ltd (Japan), Jasco (Japan), Teledyne Technologies Incorporated (US), MKS Instruments (US) Ametek, Inc (US), and Hitachi High-Tech Corporation (Japan)

Agilent Technologies, Inc (US)

Agilent Technologies offers a comprehensive portfolio of LC-MS, GC-MS, and ICP-MS in the mass spectrometry market. The company has a strong presence in North America and Europe. Over the last few years, the company has increased its R&D activities with a focus on investing a significant amount of its revenue in R&D; and will continue to have significant research and development expenditures to maintain its competitive position with a continuing flow of innovative, high-quality products and services. The company is also focusing on acquisitions, collaborations, and expansions to maintain its position in the market.

Thermo Fisher Scientific, Inc (US)

Thermo Fisher is a US-based company that offers a complete and integrated portfolio of solutions and services for laboratory research & analysis, healthcare & clinical science, manufacturing, and other fields. The company operates through four business segments, namely, Analytical Instruments, Life Sciences Solutions, Specialty Diagnostics, and Laboratory Products & Services. The Analytical Instruments business segment offers mass spectrometry products. Thermo Fisher being a major player can be attributed to its extensive portfolio of mass spectrometry equipment used for various applications. It focuses on expanding its product portfolio by introducing new and advanced mass spectrometers for customers in biotechnology, pharmaceuticals, toxicology, forensics, and other fields.

Waters Corporation (US)

Waters Corporation is among the prominent players in the mass spectrometry market. They specialize in liquid chromatography, mass spectrometry (MS), and thermal analysis systems, striving to advance scientific research worldwide. The offering for mass spectrometry covers all major types of analyzers, like quadrupoles and time of flight. Their MS portfolio includes technologies like QuanTof for high-resolution exact mass measurements, StepWave for trace component confirmation, Triwave for complex mixture characterization, and MS E for exact-mass ion spectra from samples. The company focuses on innovation, performance, and usability.

Related Reports:

Mass Spectrometry Market by Product (Instrument (Triple Quadrupole, Q-TOF, FTMS, Quadrupole, TOF), Software & Services), Sample (LC-MS, GC-MS), Application (Omics, Drug Discovery, Food, Environmental), End User (Pharma, Biotech) - Global Forecasts to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com